编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
---|---|---|---|---|
20258 | CRT0273750 | 1979939-16-6 | ≧98.0% | ![]() |
CRT0273750 modulates LPA levels in plasma and is suitable for in vivo studies. | ||||
20376 | TOFA ( RMI14514; MDL14514) | 54857-86-2 | ≧98.0% | ![]() |
TOFA (RMI14514; MDL14514) 是乙酰辅酶A 羧化酶-α (ACCA) 的变构抑制剂。在 | ||||
20102901 | Razuprotafib | 1008510-37-9 | ≧98.0% | ![]() |
Razuprotafib,也称为AKB-9778,是血管内皮蛋白酪氨酸磷酸酶(VE-PTP) | ||||
2105071 | AP1189 acetate | 959850-74-9 | ≧98.0% | ![]() |
AP1189 is a melanocortin receptor agonist on MC1 and MC3 receptors. | ||||
20103003 | ML380 | 1627138-52-6 | ≧98.0% | ![]() |
ML380 is a highly potent and the first CNS penetrant M5 positive allosteric modulator | ||||
2071535 | Danicopan | 1903768-17-1 | ≧98.0% | ![]() |
Danicopan, aslo known as ACH-4471 and ACH-0144471, is a highly potent, orally active | ||||
20259 | Elinzanetant ( NT-814 ) | 929046-33-3 | ≧98.0% | ![]() |
Elinzanetant,以前称为 NT-814 (45),是一种双重 NK1,3R 拮抗剂,因此有 | ||||
52007 | SRT1720 | 1001645-58-4 | 98% | ![]() |
SRT1720 is a selectiveSIRT1activator withEC50of 0.16 M, but is >230-fold less pote | ||||
20294 | Paltusotine ( CRN-00808 ) | 2172870-89-0 | ≧98.0% | ![]() |
Paltusotine 是一类新型的、口服、选择性、非肽类2型生长抑素受体 | ||||
19381 | Abrocitinib | 1622902-68-4 | >98% | ![]() |
Abrocitinib(PF-04965842)是Pifzer研发的是一种Janus激酶抑制剂药物,目 | ||||
24003 | NVL-655 ( ALK-IN-27 ) | 2739866-40-9 | ≧98.0% | ![]() |
NVL-655是一种新型脑渗透性ALK选择性抑制剂,旨在解决目前可用的 | ||||
61726 | Ensifentrine ( RPL554 ) | 1884461-72-6 | ≧98.0% | ![]() |
Ensifentrine (RPL554) is an investigational, first-in-class, inhaled dual inhibitor o |